RECURRENT OVARIAN CANCER TREATED BY SECONDARY CYTOREDUCTIVE SURGERY AND HIPEC

被引：0
|
作者：
Panoskaltsis, T. [1 ]
Tzavara, C. [2 ]
Pallas, N. [3 ]
Karamveri, C. [3 ]
Kiziridis, D. [4 ]
Hristakis, C. [4 ]
Kyriakopoulos, V. [3 ]
Kalakonas, A. [4 ]
Vaikos, D. [4 ]
Tentes, A-A [3 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Gynaecol Oncol Unit, Sch Med, Acad Dept 2,Aretaieion, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[3] Metropolitan Hosp, Dept Surg Oncol, Peritoneal Surface Malignancy Program, Athens, Greece
[4] Euromed Kyanous Stavros, Dept Surg Oncol, Peritoneal Surface Malignancy Program, Thessaloniki, Greece
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP947
引用
收藏
页码：A505 / A506
页数：2
相关论文
共 50 条
  • [21] Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
    Son, Joo-Hyuk
    Lee, Jimin
    Yum, Sun-Hyung
    Kim, Jeeyeon
    Kong, Tae-Wook
    Chang, Suk-Joon
    Ryu, Hee-Sug
    CANCERS, 2022, 14 (16)
  • [22] ASO Author Reflections: Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
    Claudia Marchetti
    Anna Fagotti
    Giovanni Scambia
    Francesca De Felice
    Annals of Surgical Oncology, 2021, 28 : 3264 - 3265
  • [23] Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer
    Schorge, John O.
    Wingo, Shana N.
    Bhore, Rafia
    Heffernan, Thomas P.
    Lea, Jayanthi S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (02) : 123 - 127
  • [24] Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Gockley, A. A.
    Cronin, A.
    Bookman, M. A.
    Burger, R. A.
    Cristea, M.
    Griggs, J. J.
    Mantia-Smaldone, G. M.
    Meyer, L. A.
    O'Malley, D. M.
    Wright, A. A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 81 - 82
  • [25] Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial
    Selman, AE
    Copeland, LJ
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 41 (03) : 335 - 341
  • [26] The role of iterative cytoreductive surgery in recurrent ovarian cancer: survival outcomes: beyond secondary cytoreductive surgery
    Kim, Jeeyeon
    Lee, Jimin
    Son, Joo-Hyuk
    Kong, Tae-Wook
    Chang, Suk-Joon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A182 - A183
  • [27] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for recurrent high grade serous ovarian cancer
    Lee, Jimin
    Kim, Jeeyeon
    Son, Joo-Hyuk
    Kong, Tae-Wook
    Chang, Suk-Joon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A190 - A190
  • [28] Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    Spiliotis, J.
    Halkia, E.
    Lianos, E.
    Kalantzi, N.
    Grivas, A.
    Efstathiou, E.
    Giassas, S.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1570 - 1575
  • [29] Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    J. Spiliotis
    E. Halkia
    E. Lianos
    N. Kalantzi
    A. Grivas
    E. Efstathiou
    S. Giassas
    Annals of Surgical Oncology, 2015, 22 : 1570 - 1575
  • [30] Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    M. Petrillo
    P. De Iaco
    S. Cianci
    M. Perrone
    B. Costantini
    C. Ronsini
    G. Scambia
    A. Fagotti
    Annals of Surgical Oncology, 2016, 23 : 1660 - 1665
12345